← Back to Screener
InnovAge Holding Corp. Common Stock (INNV)
Price$7.95
Favorite Metrics
Price vs S&P 500 (26W)52.51%
Price vs S&P 500 (4W)-3.17%
Market Capitalization$1.12B
All Metrics
P/CF (Annual)34.02x
Book Value / Share (Quarterly)$1.89
P/TBV (Annual)2.16x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)6.91%
Cash Flow / Share (Quarterly)$0.37
Price vs S&P 500 (YTD)54.63%
Gross Margin (TTM)20.34%
Net Profit Margin (TTM)0.71%
EPS (TTM)$0.05
10-Day Avg Trading Volume0.27M
EPS Excl Extra (TTM)$0.05
Revenue Growth (5Y)8.52%
EPS (Annual)$-0.22
ROI (Annual)-9.86%
Gross Margin (Annual)18.00%
Net Profit Margin (5Y Avg)-4.02%
Cash / Share (Quarterly)$0.93
P/E Basic Excl Extra (TTM)172.72x
Revenue Growth QoQ (YoY)14.69%
ROA (Last FY)-5.75%
Revenue Growth TTM (YoY)13.48%
EBITD / Share (TTM)$0.22
ROE (5Y Avg)-9.93%
Operating Margin (TTM)1.01%
Cash Flow / Share (Annual)$0.20
P/B Ratio4.35x
P/B Ratio (Quarterly)2.74x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.21x
Net Interest Coverage (TTM)-4.67x
ROA (TTM)1.23%
EV / EBITDA (TTM)37.01x
EPS Incl Extra (Annual)$-0.22
Current Ratio (Annual)1.07x
Quick Ratio (Quarterly)1.04x
3-Month Avg Trading Volume0.27M
52-Week Price Return190.14%
EV / Free Cash Flow (Annual)41.50x
P/E Incl Extra (TTM)172.72x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.87
P/S Ratio (Annual)1.31x
Asset Turnover (Annual)1.62x
52-Week High$10.69
Operating Margin (5Y Avg)-3.71%
EPS Excl Extra (Annual)$-0.22
CapEx CAGR (5Y)-11.96%
26-Week Price Return61.25%
Quick Ratio (Annual)0.92x
13-Week Price Return48.74%
Total Debt / Equity (Annual)0.31x
Current Ratio (Quarterly)1.26x
Enterprise Value$1,103.898
Revenue / Share Growth (5Y)8.17%
Asset Turnover (TTM)1.74x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-3.99%
Cash / Share (Annual)$0.78
3-Month Return Std Dev97.06%
Gross Margin (5Y Avg)19.34%
Net Income / Employee (TTM)$0
EBITDA Interim CAGR (5Y)-5.15%
ROE (Last FY)-12.90%
Net Interest Coverage (Annual)1.86x
EPS Basic Excl Extra (Annual)$-0.22
P/FCF (TTM)22.40x
Receivables Turnover (TTM)25.76x
EV / Free Cash Flow (TTM)22.22x
Total Debt / Equity (Quarterly)0.27x
EPS Incl Extra (TTM)$0.05
Receivables Turnover (Annual)20.21x
ROI (TTM)2.05%
P/S Ratio (TTM)1.22x
Pretax Margin (5Y Avg)-4.15%
Revenue / Share (Annual)$6.31
Tangible BV / Share (Annual)$1.71
Forward P/E31.51x
Free OCF CAGR (5Y)-3.62%
Price vs S&P 500 (52W)155.05%
P/E Ratio (TTM)172.72x
Year-to-Date Return58.77%
5-Day Price Return1.23%
EPS Normalized (Annual)$-0.22
ROA (5Y Avg)-5.25%
Net Profit Margin (Annual)-3.55%
Month-to-Date Return2.74%
Cash Flow / Share (TTM)$-0.18
EBITD / Share (Annual)$-0.06
Operating Margin (Annual)-3.49%
LT Debt / Equity (Annual)0.24x
P/CF (TTM)19.01x
ROI (5Y Avg)-7.73%
P/E Excl Extra (TTM)172.72x
LT Debt / Equity (Quarterly)0.22x
EPS Basic Excl Extra (TTM)$0.05
P/TBV (Quarterly)2.78x
P/B Ratio (Annual)2.13x
Pretax Margin (TTM)0.56%
Book Value / Share (Annual)$1.73
Price vs S&P 500 (13W)45.87%
Beta0.48x
P/FCF (Annual)42.03x
Revenue / Share (TTM)$6.71
ROE (TTM)2.66%
52-Week Low$2.60
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.25
2.33
2.33
2.33
Industry Peers — Health Services(13)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
INNVInnovAge Holding Corp. Common Stock | — | 13.48% | 1.01% | 2.66% | $7.95 |
PRVAPrivia Health Group, Inc. Common Stock | 131.66x | 22.26% | 1.61% | 3.29% | $24.08 |
LFSTLifeStance Health Group, Inc. Common Stock | 277.93x | -12.76% | 2.07% | 0.65% | $6.92 |
WGSGeneDx Holdings Corp. Class A Common Stock | — | 39.97% | -3.06% | -7.41% | $69.71 |
USPHUS Physical Therapy Inc | 28.66x | 16.33% | 11.08% | 8.00% | $75.72 |
PNTGThe Pennant Group, Inc. Common Stock | 36.33x | 36.31% | 5.47% | 9.31% | $29.64 |
TALKTalkspace, Inc. Common Stock | 111.06x | 22.00% | 1.38% | 6.89% | $5.18 |
OMDAOmada Health, Inc. Common Stock | — | — | -5.41% | -7.10% | $14.04 |
SRTAStrata Critical Medical, Inc. Class A Common Stock | 9.61x | -3.02% | -10.18% | 16.45% | $4.52 |
DCGODocGo Inc. Common Stock | 3.28x | -47.74% | -56.81% | -71.45% | $0.68 |
PIIIP3 Health Partners Inc. Common Stock | — | -2.76% | -18.53% | -191.97% | $2.83 |
About
InnovAge operates a capitated healthcare platform serving high-cost seniors, including dual-eligible beneficiaries, through its PACE (Program of All-Inclusive Care for the Elderly) model. The company's participant-centered approach delivers integrated care while keeping seniors independent at home, reducing costly hospital and nursing home admissions. This model addresses rising U.S. healthcare costs while improving care quality and outcomes.